Refactor Capital

Refactor Capital

Refactor Capital is an early-stage venture capital firm that invests in software companies.

Refactor Capital is a Burlingame, CA-based $50M early-stage venture capital firm that invests in areas such as applied biology, healthcare, crypto, food, wellness, transportation, aerospace, and more. The firm primarily invests in seed-stage companies.

As of March 2017, Refactor has invested in 20 software companies, half of them supporting healthcare and life sciences. Other areas represented in its portfolio are agriculture, financial, and legal services. The average check size is about $500,000, with the fund expecting to have around 40 to 50 companies in their portfolio.

As of January 2019, Refactor has 28 companies in its portfolio.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

A satellite communications company building small telecommunication satellites.

A biotechnology company offering genomic testing of beef and dairy cattle.

A synthetic biology company offering a bioreactor facility for fermentation on demand services.

A biotechnology company offering a DNA sequencing platform for helping to prevent antibiotic resistance.

A company replacing petroleum-based chemicals with plant-derived alternatives

A company offering a smart medication management device that is headquartered in New York City, New York and was founded in 2012 by Kal Vepuri and Kut Akdogan.

Redesign Science Inc is a computational chemistry company that is interested in small molecule drug discovery

Ophelia is a Philadelphia-based company founded by Mattan Griffel.

11 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
3,225,000
3,225,000
June 3, 2016
20,500,000
20,500,000
May 9, 2017
1,040,000
1,040,000
December 31, 2018
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

David Lee

Managing Partner

Marc Chodorow

Advisor

Nicole Wong

Advisor

Rick Barber

Venture Partner

Sara Sperling

Advisor

Suleman Ali

Investor

Tom Schoenherr

Advisor

Zal Bilimoria

Managing Partner

Further reading

Title
Author
Link
Type
Date

David Lee is back with a new fund: Refactor Capital

Connie Loizos

Web

Refactor Capital cofounder highlights seed stage fund strategy - MedCity News

Stephanie Baum

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Able Health

Health

Alloy

Logistics

Astranis

Aerospace

bulkMRO

Industrial marketplaces

Call9

Health

Cambridge Cancer Genomics

Biology

Clover Health

Health

Cofactor Genomics

Biology

News

Title0
Author0
Date0
Publisher0
Description0
Erin Brodwin
November 4, 2019
Business Insider
Zal Bilimoria, the managing director of Silicon Valley venture firm Refactor Capital, told Business Insider that "biology is eating the whole world."

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.